IL15 and cervical cancer: Functionally, OKT-3/IL-15-expanded Vδ1 cells exhibited highly consistent innate cytotoxicity against a range of hematological and solid tumor targets, including T cell leukemia Jurkat cells, cervical cancer HeLa cells, neuroblastoma LAN-1 cells, chronic myelogenous leukemia K562 cells and acute myeloid leukemia NOMO-1 cells (Figure 2E).